{
  "hits": 306,
  "size": 50,
  "data": [
    {
      "title": "主业稳健，BD交易将增厚公司业绩",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2025-11-28 00:00:00.000",
      "infoCode": "AP202511281789842939",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.57",
      "predictNextTwoYearPe": "39.6",
      "predictNextYearEps": "1.37",
      "predictNextYearPe": "45.32",
      "predictThisYearEps": "1.52",
      "predictThisYearPe": "40.83",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "83.0000000000",
      "indvAimPriceL": "83.0000000000",
      "attachType": "0",
      "attachSize": 441,
      "attachPages": 3,
      "encodeUrl": "YxC/GtsbbJslcHdNDzCgTMZuFm35WoNENkIrBPl+0OU=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "收入内生增速稳健，关注BD首付款落地节奏",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80036717",
      "orgName": "中邮证券有限责任公司",
      "orgSName": "中邮证券",
      "publishDate": "2025-11-03 00:00:00.000",
      "infoCode": "AP202511031774257377",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.7700000000",
      "predictNextTwoYearPe": "35.4600000000",
      "predictNextYearEps": "1.6100000000",
      "predictNextYearPe": "39.0100000000",
      "predictThisYearEps": "1.3800000000",
      "predictThisYearPe": "45.4700000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000260038.盛丽华",
        "11000268934.陈灿"
      ],
      "indvIsNew": "001",
      "researcher": "盛丽华,陈灿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 641,
      "attachPages": 5,
      "encodeUrl": "M3W+xvIoKL6BPVVY0LPN8Fsh10gCv70MoYmVt00btAI=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000260038",
        "11000268934"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "恒瑞医药2025年三季报业绩点评：业绩保持稳定增长，创新兑现&国际化加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2025-10-31 00:00:00.000",
      "infoCode": "AP202510311772644646",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.8300000000",
      "predictNextTwoYearPe": "35.0300000000",
      "predictNextYearEps": "1.5200000000",
      "predictNextYearPe": "42.1800000000",
      "predictThisYearEps": "1.3100000000",
      "predictThisYearPe": "49.0300000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000252536.程培",
        "11000398535.孙怡"
      ],
      "indvIsNew": "001",
      "researcher": "程培,孙怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 478,
      "attachPages": 4,
      "encodeUrl": "BZx4sIvc1ZaAK0tUYa4jh4iykgVRLSBX/eJ4JYeIII8=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536",
        "11000398535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "主业稳健增长，创新管线价值持续兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2025-10-31 00:00:00.000",
      "infoCode": "AP202510311772485934",
      "column": "002004002003",
      "predictNextTwoYearEps": "2.0600000000",
      "predictNextTwoYearPe": "30.4800000000",
      "predictNextYearEps": "1.7100000000",
      "predictNextYearPe": "36.8300000000",
      "predictThisYearEps": "1.4200000000",
      "predictThisYearPe": "44.2500000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 262,
      "attachPages": 3,
      "encodeUrl": "BZx4sIvc1ZaAK0tUYa4jhz64RUaclWHHN4cNyYm7bQM=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年三季报点评：出海屡创佳绩，创新驱动增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2025-10-30 00:00:00.000",
      "infoCode": "AP202510301771954651",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.7000000000",
      "predictNextTwoYearPe": "37.7500000000",
      "predictNextYearEps": "1.4300000000",
      "predictNextYearPe": "44.7800000000",
      "predictThisYearEps": "1.1900000000",
      "predictThisYearPe": "53.9100000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1175,
      "attachPages": 5,
      "encodeUrl": "3XOE9tuQCeYEKPg1b8QemHRhFEMqiv1BModlI5N164Q=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "近期重点关注医保谈判结果",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81070432",
      "orgName": "浦银国际证券有限公司",
      "orgSName": "浦银国际证券",
      "publishDate": "2025-10-30 00:00:00.000",
      "infoCode": "AP202510301771791308",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.46",
      "predictNextTwoYearPe": "43.5",
      "predictNextYearEps": "1.41",
      "predictNextYearPe": "45.1",
      "predictThisYearEps": "1.39",
      "predictThisYearPe": "45.7",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000459337.阳景",
        "11000344534.胡泽宇"
      ],
      "indvIsNew": "001",
      "researcher": "阳景,胡泽宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "80.0000000000",
      "indvAimPriceL": "80.0000000000",
      "attachType": "0",
      "attachSize": 775,
      "attachPages": 7,
      "encodeUrl": "3XOE9tuQCeYEKPg1b8QemKKYgUjD7UrzbsN+LA+B3/M=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000459337",
        "11000344534"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年三季报点评：国际化进程全面加速，创新研发持续兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2025-10-28 00:00:00.000",
      "infoCode": "AP202510281770767507",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.7400000000",
      "predictNextTwoYearPe": "37.0000000000",
      "predictNextYearEps": "1.4900000000",
      "predictNextYearPe": "43.0000000000",
      "predictThisYearEps": "1.4300000000",
      "predictThisYearPe": "45.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 672,
      "attachPages": 3,
      "encodeUrl": "Klp1pHCuhBSVNsxGtiNHxHWpKAp1e4ub9jRXzMkM02U=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩稳健增长，国际化进程提速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2025-10-28 00:00:00.000",
      "infoCode": "AP202510281770617244",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.8290000000",
      "predictNextTwoYearPe": "34.3600000000",
      "predictNextYearEps": "1.5790000000",
      "predictNextYearPe": "39.8000000000",
      "predictThisYearEps": "1.3500000000",
      "predictThisYearPe": "46.5600000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000406539.甘坛焕",
        "11000453031.姜铸轩"
      ],
      "indvIsNew": "001",
      "researcher": "甘坛焕,姜铸轩",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1049,
      "attachPages": 4,
      "encodeUrl": "Klp1pHCuhBSVNsxGtiNHxCJVTYi/GzLDf9NHjWB0tTA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000406539",
        "11000453031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "事件点评：出海步伐不断加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2025-09-25 00:00:00.000",
      "infoCode": "AP202509251750230290",
      "column": "002004006003",
      "predictNextTwoYearEps": "1.45",
      "predictNextTwoYearPe": "48.28",
      "predictNextYearEps": "1.26",
      "predictNextYearPe": "55.52",
      "predictThisYearEps": "1.1",
      "predictThisYearPe": "63.82",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 533,
      "attachPages": 3,
      "encodeUrl": "G0YE5X/hWaSMkflGiPYBhJLpqs4teguK/dnGJzA9pr0=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年半年报点评：对外许可常态化，员工持股计划明确创新药产出规划",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80036717",
      "orgName": "中邮证券有限责任公司",
      "orgSName": "中邮证券",
      "publishDate": "2025-09-09 00:00:00.000",
      "infoCode": "AP202509091740807521",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.7800000000",
      "predictNextTwoYearPe": "40.7000000000",
      "predictNextYearEps": "1.6200000000",
      "predictNextYearPe": "44.7600000000",
      "predictThisYearEps": "1.3800000000",
      "predictThisYearPe": "52.2900000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000260038.盛丽华",
        "11000268934.陈灿"
      ],
      "indvIsNew": "001",
      "researcher": "盛丽华,陈灿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 645,
      "attachPages": 5,
      "encodeUrl": "jOpZ8q3SeihB01PVClRo1vi9irJtUmr2/OjF1QSyUXY=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000260038",
        "11000268934"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年半年报点评：创新驱动业绩增长，BD助力成果兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2025-09-05 00:00:00.000",
      "infoCode": "AP202509051739205288",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.5900000000",
      "predictNextTwoYearPe": "43.3300000000",
      "predictNextYearEps": "1.3200000000",
      "predictNextYearPe": "52.2800000000",
      "predictThisYearEps": "1.0600000000",
      "predictThisYearPe": "65.0400000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1299,
      "attachPages": 6,
      "encodeUrl": "gRoYA8SffzXviMQ+qXIVtw0eHPkaYTd4hF3+zJv1Uh8=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "BD交易再下一单，将继续增厚公司业绩",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2025-09-05 00:00:00.000",
      "infoCode": "AP202509051739175006",
      "column": "002004006003",
      "predictNextTwoYearEps": "1.57",
      "predictNextTwoYearPe": "43.78",
      "predictNextYearEps": "1.37",
      "predictNextYearPe": "50.11",
      "predictThisYearEps": "1.52",
      "predictThisYearPe": "45.13",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "83.0000000000",
      "indvAimPriceL": "83.0000000000",
      "attachType": "0",
      "attachSize": 525,
      "attachPages": 3,
      "encodeUrl": "gRoYA8SffzXviMQ+qXIVt3gMqkVlhhmlVDfY5VLwgDY=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "医药龙头强势归来，国际化进程不断加速",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2025-08-28 00:00:00.000",
      "infoCode": "AP202508281736030917",
      "column": "002004002002",
      "predictNextTwoYearEps": "2.0600000000",
      "predictNextTwoYearPe": "30.5600000000",
      "predictNextYearEps": "1.7100000000",
      "predictNextYearPe": "36.9300000000",
      "predictThisYearEps": "1.4200000000",
      "predictThisYearPe": "44.3700000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 266,
      "attachPages": 3,
      "encodeUrl": "eqMxmRBMQHc2e285tinawowqzaeD8oG1TJaqaodx7g4=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩快速增长，创新驱动公司进入发展新阶段",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银证券",
      "publishDate": "2025-08-28 00:00:00.000",
      "infoCode": "AP202508281735932211",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.4000000000",
      "predictNextTwoYearPe": "45.4000000000",
      "predictNextYearEps": "1.2000000000",
      "predictNextYearPe": "52.5000000000",
      "predictThisYearEps": "1.0000000000",
      "predictThisYearPe": "62.4000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000296832.刘恩阳"
      ],
      "indvIsNew": "001",
      "researcher": "刘恩阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 461,
      "attachPages": 4,
      "encodeUrl": "eqMxmRBMQHc2e285tinawrl3HgPNjCe9OhX9uYZ7lTA=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000296832"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药渐入丰收期，BD收入成为业绩增长新引擎",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81070432",
      "orgName": "浦银国际证券有限公司",
      "orgSName": "浦银国际证券",
      "publishDate": "2025-08-25 00:00:00.000",
      "infoCode": "AP202508251734087609",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000459337.阳景",
        "11000344534.胡泽宇"
      ],
      "indvIsNew": "001",
      "researcher": "阳景,胡泽宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "80.0000000000",
      "indvAimPriceL": "80.0000000000",
      "attachType": "0",
      "attachSize": 872,
      "attachPages": 9,
      "encodeUrl": "JkYfBgdyh6mbw1+gP5447iQsTxS///d/scYeDUIISJg=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000459337",
        "11000344534"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年中报点评：创新药持续放量，BD成为第二增长曲线",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000031",
      "orgName": "东吴证券股份有限公司",
      "orgSName": "东吴证券",
      "publishDate": "2025-08-24 00:00:00.000",
      "infoCode": "AP202508241733689290",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.7600000000",
      "predictNextTwoYearPe": "36.3600000000",
      "predictNextYearEps": "1.5800000000",
      "predictNextYearPe": "40.4800000000",
      "predictThisYearEps": "1.4100000000",
      "predictThisYearPe": "45.4900000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000196764.朱国广"
      ],
      "indvIsNew": "001",
      "researcher": "朱国广",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 498,
      "attachPages": 3,
      "encodeUrl": "ZUVVSaPHAmnnPYirua4TMjRT4NaL2tMEn3IHf7mWJKI=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000196764"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年中报业绩点评：业绩持续高增，BD常态化提供新增长引擎",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2025-08-22 00:00:00.000",
      "infoCode": "AP202508221732190261",
      "column": "002004002002",
      "predictNextTwoYearEps": "2.0000000000",
      "predictNextTwoYearPe": "24.3100000000",
      "predictNextYearEps": "1.6900000000",
      "predictNextYearPe": "28.7600000000",
      "predictThisYearEps": "1.4100000000",
      "predictThisYearPe": "34.3600000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000252536.程培",
        "11000398535.孙怡"
      ],
      "indvIsNew": "001",
      "researcher": "程培,孙怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 387,
      "attachPages": 4,
      "encodeUrl": "oc3wy/HfHfUGbvjWcdkDZDmt9rqhqdm/nCUm9OV/RpY=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536",
        "11000398535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "主业稳步增长，BD收益增厚利润，25H1净利YOY+30%",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2025-08-21 00:00:00.000",
      "infoCode": "AP202508211731678972",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.5700000000",
      "predictNextTwoYearPe": "39.9900000000",
      "predictNextYearEps": "1.3200000000",
      "predictNextYearPe": "47.5500000000",
      "predictThisYearEps": "1.5200000000",
      "predictThisYearPe": "41.2200000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "75.4000000000",
      "indvAimPriceL": "75.4000000000",
      "attachType": "0",
      "attachSize": 518,
      "attachPages": 3,
      "encodeUrl": "fZhOEB8bnyJRXkkP6rpUTjLkq9a9/nC5zWdZQphvqVo=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2025年半年报点评：Q2业绩保持稳定增长",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2025-08-21 00:00:00.000",
      "infoCode": "AP202508211731596451",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.45",
      "predictNextTwoYearPe": "43.28",
      "predictNextYearEps": "1.26",
      "predictNextYearPe": "49.77",
      "predictThisYearEps": "1.1",
      "predictThisYearPe": "57.22",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 334,
      "attachPages": 3,
      "encodeUrl": "fZhOEB8bnyJRXkkP6rpUTpJnUUuuADDh9Z/yaq2XFvc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩高速增长，出海成效显著",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2025-08-21 00:00:00.000",
      "infoCode": "AP202508211731530733",
      "column": "002004002002",
      "predictNextTwoYearEps": "1.8290000000",
      "predictNextTwoYearPe": "34.3600000000",
      "predictNextYearEps": "1.5790000000",
      "predictNextYearPe": "39.8000000000",
      "predictThisYearEps": "1.3500000000",
      "predictThisYearPe": "46.5600000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000406539.甘坛焕",
        "11000453031.姜铸轩"
      ],
      "indvIsNew": "001",
      "researcher": "甘坛焕,姜铸轩",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1107,
      "attachPages": 4,
      "encodeUrl": "fZhOEB8bnyJRXkkP6rpUTtyrh/nGGjQmKGjoelZB4bA=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000406539",
        "11000453031"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "超预期BD交易，未来业绩有望持续释放",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2025-07-29 00:00:00.000",
      "infoCode": "AP202507291717640804",
      "column": "002004006003",
      "predictNextTwoYearEps": "2.06",
      "predictNextTwoYearPe": "30.07",
      "predictNextYearEps": "1.71",
      "predictNextYearPe": "36.34",
      "predictThisYearEps": "1.42",
      "predictThisYearPe": "43.66",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 269,
      "attachPages": 3,
      "encodeUrl": "1ty3c2DAOpK06Ey7dFpLMhzBAS8r5R+SStinOyyLqCU=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新出海交易增厚利润，25Q1净利YOY+37%",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2025-05-08 00:00:00.000",
      "infoCode": "AP202505081669479495",
      "column": "002004002003",
      "predictNextTwoYearEps": "1.63",
      "predictNextTwoYearPe": "31.62",
      "predictNextYearEps": "1.37",
      "predictNextYearPe": "37.61",
      "predictThisYearEps": "1.09",
      "predictThisYearPe": "47.11",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "006",
      "lastEmRatingValue": "2",
      "lastEmRatingName": "增持",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "64.0000000000",
      "indvAimPriceL": "64.0000000000",
      "attachType": "0",
      "attachSize": 412,
      "attachPages": 3,
      "encodeUrl": "xVw2brufnGKQXh4dfdxGc7exghgocUhiPGWt+P0beRo=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年报点评：出海佳绩不断，BD收入稳定增厚业绩",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2025-05-07 00:00:00.000",
      "infoCode": "AP202505071669018002",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.4300000000",
      "predictNextTwoYearPe": "35.1200000000",
      "predictNextYearEps": "1.2000000000",
      "predictNextYearPe": "42.0600000000",
      "predictThisYearEps": "1.0800000000",
      "predictThisYearPe": "46.5500000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000462934.王彦迪"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,王彦迪",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1260,
      "attachPages": 6,
      "encodeUrl": "nET0e/tFYNTmg7AFTkcwzToMwZ8Au+ZzgGnnMx2t1IM=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000462934"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "1Q25扣非净利润好于预期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81070432",
      "orgName": "浦银国际证券有限公司",
      "orgSName": "浦银国际证券",
      "publishDate": "2025-04-28 00:00:00.000",
      "infoCode": "AP202504281663742059",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000459337.阳景",
        "11000344534.胡泽宇"
      ],
      "indvIsNew": "001",
      "researcher": "阳景,胡泽宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "67.0000000000",
      "indvAimPriceL": "67.0000000000",
      "attachType": "0",
      "attachSize": 762,
      "attachPages": 7,
      "encodeUrl": "NimKhZl8Umo4lHwIktHNEklANXef2T7wJToa3iLJpns=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000459337",
        "11000344534"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "制药龙头稳健增长，创新研发大步向前",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银证券",
      "publishDate": "2025-04-14 00:00:00.000",
      "infoCode": "AP202504141656325545",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.4000000000",
      "predictNextTwoYearPe": "33.5000000000",
      "predictNextYearEps": "1.3000000000",
      "predictNextYearPe": "38.7000000000",
      "predictThisYearEps": "1.1000000000",
      "predictThisYearPe": "46.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000296832.刘恩阳"
      ],
      "indvIsNew": "001",
      "researcher": "刘恩阳",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 451,
      "attachPages": 4,
      "encodeUrl": "n5bXox9rN2e7v1oRd/W9J6MW+gHTSbFvXi+eRTVmTXc=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000296832"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药收入高速增长，出海渐入佳境",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2025-04-12 00:00:00.000",
      "infoCode": "AP202504121655420767",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.5500000000",
      "predictNextTwoYearPe": "31.2300000000",
      "predictNextYearEps": "1.3000000000",
      "predictNextYearPe": "37.2500000000",
      "predictThisYearEps": "1.1000000000",
      "predictThisYearPe": "44.0500000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 294,
      "attachPages": 3,
      "encodeUrl": "83KluUGijrfKZViflD1rG2tiFa7SaIrQQwejF1bnFVY=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新管线助力长期发展，出海已成第二增长引擎",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2025-04-03 00:00:00.000",
      "infoCode": "AP202504031650870999",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.4200000000",
      "predictNextTwoYearPe": "34.7300000000",
      "predictNextYearEps": "1.2300000000",
      "predictNextYearPe": "40.0600000000",
      "predictThisYearEps": "1.0700000000",
      "predictThisYearPe": "45.9700000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000418531.李蔚"
      ],
      "indvIsNew": "001",
      "researcher": "李蔚",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1067,
      "attachPages": 5,
      "encodeUrl": "emSFIp1HB04/4TKE/k8SfIVM7FNxJ7Cq94/y4FCJAPU=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000418531"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年年报点评：创新驱动卓见成效，BD加速全球布局",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2025-04-02 00:00:00.000",
      "infoCode": "AP202504021650205204",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.6100000000",
      "predictNextTwoYearPe": "32.0000000000",
      "predictNextYearEps": "1.3400000000",
      "predictNextYearPe": "39.0000000000",
      "predictThisYearEps": "1.1400000000",
      "predictThisYearPe": "45.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 869,
      "attachPages": 3,
      "encodeUrl": "9GgV0BHE7V/VB1r8O/Pmyj59QD/lNBMPWkbVPhIC1aQ=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药收入持续强劲增长，国际化加速前行",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81070432",
      "orgName": "浦银国际证券有限公司",
      "orgSName": "浦银国际证券",
      "publishDate": "2025-04-02 00:00:00.000",
      "infoCode": "AP202504021650202372",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000459337.阳景",
        "11000344534.胡泽宇"
      ],
      "indvIsNew": "001",
      "researcher": "阳景,胡泽宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "67.0000000000",
      "indvAimPriceL": "67.0000000000",
      "attachType": "0",
      "attachSize": 943,
      "attachPages": 8,
      "encodeUrl": "9GgV0BHE7V/VB1r8O/PmyjruzneA8k5OS/Hm6CB7A6k=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000459337",
        "11000344534"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药和对外合作推动业绩高增长，后续BD机会仍可观，上调目标价",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80101832",
      "orgName": "交银国际证券有限公司",
      "orgSName": "交银国际证券",
      "publishDate": "2025-04-01 00:00:00.000",
      "infoCode": "AP202504011649921238",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.541",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.293",
      "predictNextYearPe": "",
      "predictThisYearEps": "1.116",
      "predictThisYearPe": "44",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "004",
      "emRatingValue": "0",
      "emRatingName": "中性",
      "lastEmRatingCode": "004",
      "lastEmRatingValue": "0",
      "lastEmRatingName": "中性",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000444538.丁政宁",
        "11000472050.诸葛乐懿"
      ],
      "indvIsNew": "001",
      "researcher": "丁政宁,诸葛乐懿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "51.0000000000",
      "indvAimPriceL": "51.0000000000",
      "attachType": "0",
      "attachSize": 376,
      "attachPages": 6,
      "encodeUrl": "oVsFMRnefdemR2yNjNTu/UbgRNJdEV0eCPkH1bczfjE=",
      "sRatingName": "中性",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000444538",
        "11000472050"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年净利YOY+47%，创新药快速增长，创新出海交易增厚利润",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000119",
      "orgName": "群益证券(香港)有限公司",
      "orgSName": "群益证券",
      "publishDate": "2025-04-01 00:00:00.000",
      "infoCode": "AP202504011649918718",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.63",
      "predictNextTwoYearPe": "30.18",
      "predictNextYearEps": "1.37",
      "predictNextYearPe": "35.89",
      "predictThisYearEps": "1.09",
      "predictThisYearPe": "44.95",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "006",
      "emRatingValue": "2",
      "emRatingName": "增持",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": [
        "11000210658.王睿哲"
      ],
      "indvIsNew": "001",
      "researcher": "王睿哲",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "64.0000000000",
      "indvAimPriceL": "64.0000000000",
      "attachType": "0",
      "attachSize": 407,
      "attachPages": 3,
      "encodeUrl": "oVsFMRnefdemR2yNjNTu/XE2Vf/q5/C7Eui3iIoBIGU=",
      "sRatingName": "买进(Buy)",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000210658"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年年报业绩点评：收入利润创新高，创新&授权收入增长强劲",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2025-04-01 00:00:00.000",
      "infoCode": "AP202504011649825512",
      "column": "002004002001",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000252536.程培",
        "11000398535.孙怡"
      ],
      "indvIsNew": "",
      "researcher": "程培,孙怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1726,
      "attachPages": 4,
      "encodeUrl": "oVsFMRnefdemR2yNjNTu/bHI6i9HFJStvuane1UGwtk=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536",
        "11000398535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "新分子研发结硕果，海外授权持续兑现",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2025-03-31 00:00:00.000",
      "infoCode": "AP202503311649509874",
      "column": "002004002001",
      "predictNextTwoYearEps": "1.4000000000",
      "predictNextTwoYearPe": "34.7100000000",
      "predictNextYearEps": "1.2080000000",
      "predictNextYearPe": "40.2400000000",
      "predictThisYearEps": "1.0890000000",
      "predictThisYearPe": "44.6400000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 900,
      "attachPages": 4,
      "encodeUrl": "82zRwMmRKPoVFTrNGXkhZw7oCeNEeCdpvYKCgZBl+b0=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药迈入收获期，国际化加速前行",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81070432",
      "orgName": "浦银国际证券有限公司",
      "orgSName": "浦银国际证券",
      "publishDate": "2024-11-28 00:00:00.000",
      "infoCode": "AP202411281641100230",
      "column": "002004001002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.21",
      "predictNextYearPe": "41.7",
      "predictThisYearEps": "1.03",
      "predictThisYearPe": "49.1",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000459337.阳景",
        "11000344534.胡泽宇"
      ],
      "indvIsNew": "001",
      "researcher": "阳景,胡泽宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "61.0000000000",
      "indvAimPriceL": "61.0000000000",
      "attachType": "0",
      "attachSize": 1891,
      "attachPages": 77,
      "encodeUrl": "qj8YTkO72w9t0Bs7t9FglHcm5Rq/unUgOVamFWIWQhE=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000459337",
        "11000344534"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药龙头新药加速商业化，代谢、自免管线进入收获期",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000080",
      "orgName": "山西证券股份有限公司",
      "orgSName": "山西证券",
      "publishDate": "2024-11-19 00:00:00.000",
      "infoCode": "AP202411191640954505",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2600000000",
      "predictNextYearPe": "38.0000000000",
      "predictThisYearEps": "1.1000000000",
      "predictThisYearPe": "43.2000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": 2,
      "reportType": 2,
      "author": [
        "11000182544.魏赟",
        "11000177400.邓周宇"
      ],
      "indvIsNew": "001",
      "researcher": "魏赟,邓周宇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 441,
      "attachPages": 6,
      "encodeUrl": "WO/AxfYv9AswuivvEq1lchmurB+GiA6xtilQ35RwcuM=",
      "sRatingName": "买入",
      "sRatingCode": "0103",
      "market": "SHANGHAI",
      "authorID": [
        "11000182544",
        "11000177400"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩符合预期，创新药研发顺利推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2024-10-31 00:00:00.000",
      "infoCode": "AP202410311640634079",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2500000000",
      "predictNextYearPe": "38.4800000000",
      "predictThisYearEps": "1.0200000000",
      "predictThisYearPe": "46.9700000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000418531.李蔚"
      ],
      "indvIsNew": "001",
      "researcher": "李蔚",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 950,
      "attachPages": 4,
      "encodeUrl": "ZZVcWyZlNYBQxiDJmf/AVgGcP8npVW0TYPLAKtfth0o=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000418531"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "经营稳健增长，坚持科技创新和国际化发展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2024-10-29 00:00:00.000",
      "infoCode": "AP202410291640562007",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2700000000",
      "predictNextYearPe": "38.1700000000",
      "predictThisYearEps": "1.1100000000",
      "predictThisYearPe": "43.9200000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 337,
      "attachPages": 3,
      "encodeUrl": "uu9JPWWGabf0EZv7aS6GcB0pwG2KLYRxIjrgrBvSUrs=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "3Q收入延续复苏态势、但利润率略有承压，维持中性评级",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80101832",
      "orgName": "交银国际证券有限公司",
      "orgSName": "交银国际证券",
      "publishDate": "2024-10-29 00:00:00.000",
      "infoCode": "AP202410291640558233",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.192",
      "predictNextYearPe": "",
      "predictThisYearEps": "0.98",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "004",
      "emRatingValue": "0",
      "emRatingName": "中性",
      "lastEmRatingCode": "004",
      "lastEmRatingValue": "0",
      "lastEmRatingName": "中性",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000444538.丁政宁",
        "11000472050.诸葛乐懿"
      ],
      "indvIsNew": "001",
      "researcher": "丁政宁,诸葛乐懿",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "45.0000000000",
      "indvAimPriceL": "45.0000000000",
      "attachType": "0",
      "attachSize": 374,
      "attachPages": 6,
      "encodeUrl": "uu9JPWWGabf0EZv7aS6GcJCLlhL4mZGlsOzHMtciRwE=",
      "sRatingName": "中性",
      "sRatingCode": "0202",
      "market": "SHANGHAI",
      "authorID": [
        "11000444538",
        "11000472050"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩保持稳定增长，推进创新出海和研发进展",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银证券",
      "publishDate": "2024-10-28 00:00:00.000",
      "infoCode": "AP202410281640551618",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.3000000000",
      "predictNextYearPe": "38.9000000000",
      "predictThisYearEps": "1.1000000000",
      "predictThisYearPe": "46.3000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000296832.刘恩阳",
        "11000450337.薛源"
      ],
      "indvIsNew": "001",
      "researcher": "刘恩阳,薛源",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 524,
      "attachPages": 4,
      "encodeUrl": "WMroo3CFSx+yKaZ4146xyzll4T73/AAzZ+fIqLTV02I=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000296832",
        "11000450337"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年三季报点评，坚持创新战略，国内进入收获期，出海双线推进",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2024-10-27 00:00:00.000",
      "infoCode": "AP202410271640526282",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2600000000",
      "predictNextYearPe": "38.0000000000",
      "predictThisYearEps": "1.0500000000",
      "predictThisYearPe": "46.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 866,
      "attachPages": 3,
      "encodeUrl": "qOgMjjTwPbYnSJ8Of/DqCx77cHC/EOgdC0gzYZEBaNA=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年三季报点评：Q3业绩增速环比有所放缓",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2024-10-25 00:00:00.000",
      "infoCode": "AP202410251640496729",
      "column": "002004002003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.23",
      "predictNextYearPe": "39.45",
      "predictThisYearEps": "1.07",
      "predictThisYearPe": "45.55",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 479,
      "attachPages": 3,
      "encodeUrl": "WAkuK/k2CrJo9hevI1ZbSx+WLAmlwv/x1lEkZKygIh4=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新产品放量驱动高速增长，股权激励彰显发展信心",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000197",
      "orgName": "中航证券有限公司",
      "orgSName": "中航证券",
      "publishDate": "2024-08-26 00:00:00.000",
      "infoCode": "AP202408261639445626",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000418531.李蔚"
      ],
      "indvIsNew": "001",
      "researcher": "李蔚",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 613,
      "attachPages": 4,
      "encodeUrl": "HqVKLTox5y/k3ddRtYzXz3qAGaj3wR5sJZ7PGimmrlA=",
      "sRatingName": "买入",
      "sRatingCode": "0102",
      "market": "SHANGHAI",
      "authorID": [
        "11000418531"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "出海贡献业绩增量，新药快速放量，转型成果显著",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80042949",
      "orgName": "华源证券股份有限公司",
      "orgSName": "华源证券",
      "publishDate": "2024-08-25 00:00:00.000",
      "infoCode": "AP202408251639441510",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000247045.刘闯"
      ],
      "indvIsNew": "001",
      "researcher": "刘闯",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 439,
      "attachPages": 2,
      "encodeUrl": "oDdRCghrhZO8/P/6EEOaTbNsHCl3PQzOB+wobjCPnW8=",
      "sRatingName": "买入",
      "sRatingCode": "0101",
      "market": "SHANGHAI",
      "authorID": [
        "11000247045"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年半年报点评：创新药收入快速增长，出海贡献业绩新增量",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000296",
      "orgName": "西南证券股份有限公司",
      "orgSName": "西南证券",
      "publishDate": "2024-08-23 00:00:00.000",
      "infoCode": "AP202408231639426748",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2300000000",
      "predictNextYearPe": "34.2900000000",
      "predictThisYearEps": "1.0300000000",
      "predictThisYearPe": "41.1700000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000254058.杜向阳",
        "11000473735.刘潇"
      ],
      "indvIsNew": "001",
      "researcher": "杜向阳,刘潇",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1232,
      "attachPages": 5,
      "encodeUrl": "fUdhMvVNej2e8wNEXTzM490EyNZMfU0BDIX9UQGKa/U=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000254058",
        "11000473735"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年半年报点评：双轮创新驱动业绩大增，管线丰富进展不断",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000038",
      "orgName": "民生证券股份有限公司",
      "orgSName": "民生证券",
      "publishDate": "2024-08-23 00:00:00.000",
      "infoCode": "AP202408231639413064",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.2700000000",
      "predictNextYearPe": "35.0000000000",
      "predictThisYearEps": "1.0500000000",
      "predictThisYearPe": "42.0000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000321136.王班",
        "11000442933.王维肖"
      ],
      "indvIsNew": "001",
      "researcher": "王班,王维肖",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 864,
      "attachPages": 3,
      "encodeUrl": "fUdhMvVNej2e8wNEXTzM40EfDg03WvqPH1yeM5f6wYs=",
      "sRatingName": "推荐",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000321136",
        "11000442933"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年中报业绩点评：Q2业绩表现亮眼，创新&授权收入增长强劲",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000135",
      "orgName": "中国银河证券股份有限公司",
      "orgSName": "中国银河",
      "publishDate": "2024-08-22 00:00:00.000",
      "infoCode": "AP202408221639407985",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.4700000000",
      "predictNextYearPe": "28.7400000000",
      "predictThisYearEps": "1.2400000000",
      "predictThisYearPe": "34.0700000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000252536.程培",
        "11000398535.孙怡"
      ],
      "indvIsNew": "001",
      "researcher": "程培,孙怡",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 413,
      "attachPages": 4,
      "encodeUrl": "0PFUhvln7dKpgXmoVIzKGKryQT0u4aX0DIZzS3ycTzk=",
      "sRatingName": "推荐",
      "sRatingCode": "0104",
      "market": "SHANGHAI",
      "authorID": [
        "11000252536",
        "11000398535"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "业绩增速亮眼，积极加速海外布局与管线建设",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000200",
      "orgName": "中银国际证券股份有限公司",
      "orgSName": "中银证券",
      "publishDate": "2024-08-22 00:00:00.000",
      "infoCode": "AP202408221639397857",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.3000000000",
      "predictNextYearPe": "33.8000000000",
      "predictThisYearEps": "1.1000000000",
      "predictThisYearPe": "40.3000000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000296832.刘恩阳",
        "11000450337.薛源"
      ],
      "indvIsNew": "001",
      "researcher": "刘恩阳,薛源",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 637,
      "attachPages": 4,
      "encodeUrl": "0PFUhvln7dKpgXmoVIzKGGHI6lifg8uHvt4mCXcyfDU=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000296832",
        "11000450337"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "创新药业务拉动营收快速增长，对外授权收入提供额外增长动力",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "10000082",
      "orgName": "国金证券股份有限公司",
      "orgSName": "国金证券",
      "publishDate": "2024-08-22 00:00:00.000",
      "infoCode": "AP202408221639393026",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.3070000000",
      "predictNextYearPe": "32.3600000000",
      "predictThisYearEps": "1.0770000000",
      "predictThisYearPe": "39.2800000000",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000280240.袁维"
      ],
      "indvIsNew": "001",
      "researcher": "袁维",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 953,
      "attachPages": 4,
      "encodeUrl": "0PFUhvln7dKpgXmoVIzKGL9+5Z+ABoIRjc8YBvCbEqE=",
      "sRatingName": "买入",
      "sRatingCode": "0301",
      "market": "SHANGHAI",
      "authorID": [
        "11000280240"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "2024年半年报点评：Q2业绩增速环比提升",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "80000081",
      "orgName": "东莞证券股份有限公司",
      "orgSName": "东莞证券",
      "publishDate": "2024-08-22 00:00:00.000",
      "infoCode": "AP202408221639391570",
      "column": "002004002002",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "1.23",
      "predictNextYearPe": "34.29",
      "predictThisYearEps": "1.07",
      "predictThisYearPe": "39.6",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "007",
      "emRatingValue": "3",
      "emRatingName": "买入",
      "lastEmRatingCode": "007",
      "lastEmRatingValue": "3",
      "lastEmRatingName": "买入",
      "ratingChange": 3,
      "reportType": 2,
      "author": [
        "11000412835.谢雄雄"
      ],
      "indvIsNew": "001",
      "researcher": "谢雄雄",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 493,
      "attachPages": 3,
      "encodeUrl": "0PFUhvln7dKpgXmoVIzKGMxobPMf9hvfwb9NxCJYidI=",
      "sRatingName": "买入",
      "sRatingCode": "0201",
      "market": "SHANGHAI",
      "authorID": [
        "11000412835"
      ],
      "count": 1,
      "orgType": "white"
    },
    {
      "title": "再次成功转型，创新药已成为增长新引擎，静待启航",
      "stockName": "恒瑞医药",
      "stockCode": "600276",
      "orgCode": "81251603",
      "orgName": "亿渡数据",
      "orgSName": "亿渡数据",
      "publishDate": "2024-05-30 00:00:00.000",
      "infoCode": "AP202405301634930562",
      "column": "002004001003",
      "predictNextTwoYearEps": "",
      "predictNextTwoYearPe": "",
      "predictNextYearEps": "",
      "predictNextYearPe": "",
      "predictThisYearEps": "",
      "predictThisYearPe": "",
      "predictLastYearEps": "",
      "predictLastYearPe": "",
      "actualLastTwoYearEps": "",
      "actualLastYearEps": "",
      "industryCode": "",
      "industryName": "",
      "emIndustryCode": "",
      "indvInduCode": "465",
      "indvInduName": "化学制药",
      "emRatingCode": "",
      "emRatingValue": "",
      "emRatingName": "",
      "lastEmRatingCode": "",
      "lastEmRatingValue": "",
      "lastEmRatingName": "",
      "ratingChange": "",
      "reportType": 2,
      "author": "",
      "indvIsNew": "001",
      "researcher": "",
      "newListingDate": "2000-10-18 00:00:00.000",
      "newPurchaseDate": "2000-09-07 00:00:00.0",
      "newIssuePrice": 11.98,
      "newPeIssueA": 31.44,
      "indvAimPriceT": "",
      "indvAimPriceL": "",
      "attachType": "0",
      "attachSize": 1156,
      "attachPages": 19,
      "encodeUrl": "e1bLkqqRqto0bfapIbioQCWDpq1IAI+UemYQfkJfQuA=",
      "sRatingName": "",
      "sRatingCode": "",
      "market": "SHANGHAI",
      "authorID": "",
      "count": 1,
      "orgType": "white"
    }
  ],
  "TotalPage": 7,
  "pageNo": 1,
  "currentYear": 2025
}